Solid/Hollow depots for drug delivery, Part 1: Effect of drug characteristics and polymer molecular weight on the phase-inversion dynamics, depot morphology, and drug release

Journal of Pharmaceutical Sciences

Volumn 103, Issue 2, 2014, Pages 485-495

  Liu, Hui ^a   Venkatraman, Subbu S ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Controlled release delivery; Desolvation; Diffusion; Injectable depots; Phase transition; Poly(lactic glycolic) acid (PLGA or PLA); Polymer degradation

Indexed keywords

METOCLOPRAMIDE; POLYGLACTIN; POLYMER;

ARTICLE; CONTROLLED RELEASE FORMULATION; DEGRADATION KINETICS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; HYDROPHILICITY; MOLECULAR WEIGHT; PH MEASUREMENT; PHASE TRANSITION;

CONTROLLED RELEASE/DELIVERY; DESOLVATION; DIFFUSION; INJECTABLE DEPOTS; PHASE TRANSITION; POLY(LACTIC/GLYCOLIC) ACID (PLGA OR PLA); POLYMER DEGRADATION;

DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FREEZE DRYING; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; POLYMERS; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; SURFACE PROPERTIES; WATER;

EID: 84895918293     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23790     Document Type: Article

References (40)

1. Heller J. 1993. Polymers for controlled parenteral delivery of peptides and proteins. Adv Drug Deliv Rev 10:163-204.
2. Reddy KR. 2000. Controlled release, pegylation, liposomal formulations: New mechanisms in the delivery of injectable drugs. Ann Pharmacother 34:915-922.
3. Levy RJ, Labhasetwar V, Strickberger SA, Underwood T, Davis J. 1996. Controlled release implant dosage forms for cardiac arrhythmias: Review and perspectives. Drug Deliv 3:137-142.
4. Brodbeck KJ, DesNoyer JR, McHugh AJ. 1999. Phase inversion dynamics of PLGA solutions related to drug delivery part II. The role of solution thermodynamics and bath-side mass transfer. J Control Release 62:333-344.
5. Graham PD, Brodbeck KJ, McHugh AJ. 1999. Phase inversion dynamics of PLGA solutions related to drug delivery. J Control Release 58:233-245.
6. Dunn RL, English JP, Cowsar DR, Vanderbilt DP. 1990. Biodegradable in-situ forming implants and methods of producing the same. Patent US4938763.
7. Dunn RL, Tipton AJ. 1997. Polymeric compositions useful as controlled release implants. Patent US5702716.
8. Dunn RL, Garrett JS, Ravivarapu H, Chandrashekar BL. 2003. Polymeric delivery formulations of leuprolide with improved efficacy. Patent US6565874.
9. Wu XS. 1995. Synthesis and properties of biodegradable lactic/ glycolic acid polymers. Encyclopedic handbook of biomaterials and bioengineering. New York: Marcel Dekker, pp 1015-1054.
10. Luan X, Bodmeier R. 2006. Influence of the poly(lactide-coglycolide) type on the leuprolide release from in situ forming microparticle systems. J Control Release 110(2):266-272.
11. Liu H, Venkatraman SS. 2012. Effect of polymer type on the dynamics of phase inversion and drug release in injectable in situ gelling systems. J Biomater Sci 23:251-266.
12. Ahmed TA, Ibrahim HM, Ibrahim F, Samy AM, Kaseem A, Nutan MT, Hussain MD. 2012. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol. J Pharm Sci 101(10):3753-3762.
13. Hasirci V, Lewandrowski K, Gresser JD, Wise DL, Trantolo DJ. 2001. Versatility of biodegradable biopolymers: Degradability and in vivo application. J Biotechnol 86:135-150.
14. Dong WY, Körber M, Esguerra VL, Bodmeier R. 2006. Stability of poly(D, L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems. J Control Release 115:158-167.
15. Schliecker G, Schmidt C, Fuchs S, Kissel T. 2003. Characterization of a homologous series of D, L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro. Biomaterials 24(21):3835-3844.
16. Lee S-H, Kim SH, Han Y-K, Kim YH. 2001. Synthesis and degradation of end-group-functionalized polylactide. J Polym Sci 39:973-985.
17. Wu L, Ding J. 2004. In vitro degradation of three-dimensional porous poly(D, L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 25:5821-5830.
18. Miyajima M, Koshika A, Okada Ji, Ikeda M, Nishimura K. 1997. Effect of polymer crystallinity on papaverine release from poly (L-lactic acid) matrix. J Control Release 49:207-215.
19. Pitt CG, Zhong-wei G. 1987. Modification of the rates of chain cleavage of poly(g-caprolactone) and related polyesters in the solid state. J Control Release 4:283-292.
20. Tan L, Venkatraman S, Sung P, Wang X. 2004. Effect of plasticization on heparin release from biodegradable matrices. Int J Pharm 283(1-2):89-96.
21. Grizzi I, Garreau H, Li S, Vert M. 1995. Hydrolytic degradation of devices based on poly(-lactic acid) size-dependence. Biomaterials 16:305-311.
22. Shah SS, Cha Y, Pitt CG. 1992. Poly(glycolic acid-co-DL-lactic acid): Diffusion or degradation controlled drug delivery? J Control Release 18:261-270.
23. Lu L, Peter SJ, LyMan MD, Lai HL, Leite SM, Tamada JA, Uyama S, Vacanti JP, Langer R, Mikos AG. 2000. In vitro and in vivo degradation of porous poly (D, L-lactic-co-glycolic acid) foams. Biomaterials 21:1837-1845.
24. Zolnik BS, Burgess DJ. 2007. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 122(3):338-344.
25. Chu CC. 1981. The in-vitro degradation of poly(glycolic acid) sutures-Effect of pH. J Biomed Mater Res 15:795-804.
26. Miyajima M, Koshika A, Okada Ji, Ikeda M. 1999. Mechanism of drug release from poly(image-lactic acid) matrix containing acidic or neutral drugs. J Control Release 60:199-209.
27. Alexis F. 2005. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polym Int 54(1):36-46.
28. Li S, Girod-Holland S, Vert M. 1996. Hydrolytic degradation of poly(image-lactic acid) in the presence of caffeine base. J Control Release 40:41-53.
29. Klose D, Siepmann F, Elkharraz K, Siepmann J. 2008. PLGA-based drug delivery systems: Importance of the type of drug and device geometry. Int J Pharm 354(1-2):95-103.
30. Maulding HV, Tice TR, Cowsar DR, Fong JW, Pearson JE, Nazareno JP. 1986. Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. J Control Release 3:103-117.
31. Li S. 1999. Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomed Mater Res 48:342-353.
32. Patel RB, Carlson AN, Solorio L, Exner AA. 2010. Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems. J Biomed Mater Res A 94(2):476-484.
33. Astaneh R, Erfan M, Moghimi H, Mobedi H. 2009. Changes in morphology of in situ forming PLGA implant prepared by different polymer molecularweight and its effect on release behavior. J Pharm Sci 98:135-145.
34. Astaneh R, Moghimi HR, Erfan M, Mobedi H. 2006. Formulation of an injectable implant for peptide delivery and mechanistic study of the effect of polymer molecular weight on its release behavior. DARU J Pharm Sci 14:65-70.
35. Eliaz RE, Kost J. 2000. Characterization of a polymeric PLGAinjectable implant delivery system for the controlled release of proteins. J Biomed Mater Res 50:388-396.
36. Wang L, Venkatraman S, kleiner L. 2004. Drug release from injectable depots: Two different in vitro mechanisms. J Control Release 99:207-216.
37. Miyajima M, Koshika A, Okada Ji, Kusai A, Ikeda M. 1998. The effects of drug physico-chemical properties on release from copoly (lacticglycolic acid) matrix. Int J Pharm 169:255-263.
38. Perugini P, Genta I, Conti B, Modena T, Pavanetto F. 2001. Longterm release of clodronate from biodegradable microspheres. AAPS Pharm Sci Tech 2(3):E10.
39. Zilberman M, Grinberg O. 2008. HRP-loaded bioresorbable microspheres: Effect of copolymer composition and molecular weight on microstructure and release profile. J Biomater Appl 22(5):391-407.
40. Smolders CA, Reuvers AJ, Boom RM, Wienk IM. 1992. Microstructures in phase-inversion membranes. Part 1. Formation of macrovoids. J Membr Sctence 73:259-275.